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Digitalis glycosides are major tools for the identiﬁca-
tion of the Na/K ATPase as well as the Na/K ﬂuxes me-
diated by this transport system. Since its discovery 50 yr
ago (Schatzmann, 1953), the inhibitory effect of these
compounds on the Na/K pump has been conﬁrmed re-
peatedly. There has been evidence to contrary effects,
although. Thus, Hougen et al. (1981) reported a stimu-
latory effect of nanomolar concentrations of ouabain
on 
 
86
 
Rb uptake in guinea pig atria. This effect could be
suppressed by propranolol, or by prior depletion of en-
dogenous pools of norepinephrine in the tissue, and it
was regarded as an indirect effect elicited by norepi-
nephrine released by an action of ouabain on nerve
endings in the heart.
Several others have reported stimulating effects of
low concentrations of cardiac glycosides on active Na/K
transport in multicellular cardiac preparations, and
also in the squid axon, it was noted that the inhibitory
effect of ouabain on 
 
22
 
Na efﬂux was preceded by an up
to 20% stimulation possibly related to the low occu-
pancy of the receptors in the early phase of exposure
(Baker and Willis, 1972).
Now, in this issue of 
 
The Journal
 
, Gao et al. (2002),
using whole-cell patch-clamp technique, have demon-
strated that dihydro-ouabain and ouabain in the con-
centration range 10
 
 
 
10
 
–10
 
 
 
7
 
 M stimulate the Na/K
pump–mediated current in single cardiac myocytes ob-
tained from guinea pigs, dogs, and human subjects.
The major advantage of this approach is that effects
arising from localized changes in the ionic composition
of the interstitial space or the release of endocrine fac-
tors from endogenous pools can be excluded. That this
stimulatory effect is exerted directly on the Na/K
pump is demonstrated by the observations that it is
abolished by the omission of Na
 
 
 
 from the pipette solu-
tion or of K
 
 
 
 from the buffer surrounding the cells as
well as by the addition of the Na/K pump inhibitor van-
adate to the pipette solution.
Thus, there is good evidence that cardiac glycosides at
low concentrations within a few minutes elicit up to 35 
 
 
 
10% stimulation of the Na/K pump in cardiac myocytes.
Moreover, there is indirect evidence that this reﬂects an
even larger (107 
 
 
 
 30%) stimulation of the 
 
 
 
2
 
 subunit
isoform of the Na/K ATPase. Does this imply that dur-
ing digitalization, where the plasma concentration of
digoxin is 
 
 
 
1 nM, the Na/K pumps in the heart are stim-
ulated rather than inhibited? Probably not, as it would
be in conﬂict with a number of observations. For exam-
ple, intravenous infusion of ouabain in a therapeutic
dose induces a signiﬁcant net loss of K
 
 
 
 from the human
myocardium within 2–4 min, which is an effect that is as-
sociated with signiﬁcant increases in systolic ejection rate
and left ventricular dp/dt (Brennan et al., 1972). More
recently, it was shown that in atrial tissue obtained from
patients in standard digoxin treatment, the electrogenic
effect of the Na/K pump was signiﬁcantly reduced (Ras-
mussen et al., 1990). In addition, there is strong evi-
dence that the inotropic action of cardiac glycosides is
related to an inhibition of the Na/K pump (Levi et
al.,  1994). Moreover, standard digitalization increases
exercise-induced hyperkalemia, reﬂecting a marked in-
crease in the net loss of K
 
 
 
 from the working muscles,
most likely arising from reduced Na/K pump capacity
(Schmidt et al., 1995). In biopsies obtained from the
heart and skeletal muscle of digitalized patients, 24 and
13%, respectively, of the Na/K pumps are occupied by
digoxin (Schmidt et al., 1993). There is no evidence that
standard digitalization is associated with stimulation of
the Na/K pump. Finally, it should be noted that in digi-
talized subjects, no signiﬁcant increase in the content of
[
 
3
 
H]ouabain binding sites could be detected, neither in
skeletal muscle nor heart (Schmidt et al., 1993). Thus, in
the intact organism, it has not been possible to discern
the compensatory upregulation of Na/K pumps taking
place in cell cultures during long-term exposure to oua-
bain. Hence, stimulation of active Na/K transport aris-
ing from an increased population of Na/K pump seems
to be an unlikely response to low concentrations of car-
diac glycosides in vivo.
What could be the physiological signiﬁcance of the
stimulating effect of dihydro-ouabain and ouabain on
the Na/K pump? The relative increase in active Na
 
 
 
transport is of the same order of magnitude as that elic-
ited by catecholamines or insulin in resting skeletal
muscle (Clausen, 1986), but far below the acute 10–20-
fold increase in active Na/K transport elicited by elec- 
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trical stimulation in skeletal muscle (Juel, 1986; Nielsen
and Clausen, 1997). Gao et al. (2002) suggest that the
stimulation could represent another mechanism of iso-
form-speciﬁc regulation, possibly exerted by endoge-
nous glycoside like compounds.
Unfortunately, however, despite decades of efforts in
numerous laboratories, endogenous cardiac glycoside
compounds have not yet been isolated, completely puri-
ﬁed, and chemically identiﬁed. It was proposed that oua-
bain secreted from the adrenals is present in human
plasma. However, later studies were not able to conﬁrm
these observations (Lewis et al., 1994). A quantitative
analysis revealed that with the proposed rate of ouabain
secretion from the adrenals, it would take 26 d to occupy
only 1% of the entire pool of ouabain binding sites
present in skeletal muscle (Hansen, 1994). Moreover,
the metabolic pathways required for the synthesis of oua-
bain are speciﬁc to plants and have not been described
in normal mammalian cells (Goto et al., 1992). The evi-
dence suggesting the existence of endogenous cardiac
glycoside compounds is indirect and based on studies
with antibodies and incompletely puriﬁed preparations
(for review see Goto et al., 1992). As concluded in a re-
cent review (Therien and Blostein, 2000), the chemical
properties of these compounds must be characterized
more precisely before a consensus can be reached about
their physiological signiﬁcance.
 
Perspectives
 
In spite of these reservations, the observations of Gao
et al. (2002) provide further incitements to the re-
search on endogenous digitalis-like factors. There is a
pressing need to characterize the effects of long-term
exposure to ouabain and to search for the existence of
similar effects of small concentrations of cardiac glyco-
sides in other preparations, not to mention to search
for possible effects on translocation and the afﬁnity of
the Na/K pump for Na
 
 
 
 and K
 
 
 
. More importantly, if
such phenomena are general, they may reveal new mo-
lecular information about how the Na/K pump is work-
ing and regulated. For instance, it should now be con-
sidered that regulation of the Na/K pump may be ex-
erted via an action on the outer surface of the plasma
membrane at the digitalis receptor, in addition to the
traditional view the Na/K pump is regulated, for in-
stance, via cAMP and protein kinase A from the cyto-
plasmic side of the plasma membrane.
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